▶ 調査レポート

バイオ外科手術の世界市場2021-2026:成長・動向・新型コロナの影響・市場予測

• 英文タイトル:Biosurgery Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

Mordor Intelligenceが調査・発行した産業分析レポートです。バイオ外科手術の世界市場2021-2026:成長・動向・新型コロナの影響・市場予測 / Biosurgery Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026) / MRC2103C139資料のイメージです。• レポートコード:MRC2103C139
• 出版社/出版日:Mordor Intelligence / 2021年2月27日
• レポート形態:英文、PDF、114ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥561,000 (USD4,250)▷ お問い合わせ
  Team User¥627,000 (USD4,750)▷ お問い合わせ
  Corporate License¥990,000 (USD7,500)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査資料では、世界のバイオ外科手術市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別(骨移植代替物、軟組織アタッチメント、止血剤、手術用シーラント・接着剤、癒着防止バリア、ステープルライン強化)分析、用途別(整形外科手術、一般外科手術、脳神経外科手術、心臓血管外科手術、婦人科手術、その他)分析、地域別分析、競争状況、市場機会/将来の見通しなどを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界のバイオ外科手術市場規模:製品別(骨移植代替物、軟組織アタッチメント、止血剤、手術用シーラント・接着剤、癒着防止バリア、ステープルライン強化)
・世界のバイオ外科手術市場規模:用途別(整形外科手術、一般外科手術、脳神経外科手術、心臓血管外科手術、婦人科手術、その他)
・世界のバイオ外科手術市場規模:地域別
・競争状況
・市場機会/将来の見通し

The major factors attributing to the growth of the biosurgery market are increasing geriatric population, rising prevalence of chronic diseases and related surgeries, and a strong focus on R&D leading to the launch of new and advanced products.

The global increase in the number of geriatrics population and obese people is likely to lead to numerous health consequences, like greater incidences of ortho and neuro problems. Consequently, the geriatric population and population with obesity are at a higher risk of multiple disorders and diseases.

According to the United Nations report in 2017, there were an estimated 962 million people aged 60 or over in the world, comprising 13% of the global population. The population aged 60 or above is growing at a rate of about 3% per year. It was estimated that Europe had the highest percentage of the population aged 60 or over in 2017. Thus, the rise in the geriatric and obese population is acting as a major driver for the growth of the biosurgery market.

Key Market Trends

Neurology Segment is Expected to Grow with Good CAGR in the Application Segment

Neurology and spine-related surgery applications of biosurgery are the major market segments and their growth is driven by a mainly wide application of bone graft substitute products in different biosurgery processes.

Another major application segment of biosurgery is the cardiovascular surgery segment that is expected to grow with a positive CAGR in the forecast period, and factors such as the increasing number of cardiac problems in the people across the globe are augmenting the market growth.

North America is Expected to Dominates the Market in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. This is due to the increasing number of surgeries, rising obese patients, and increasing geriatric population.

In the North America region, the United States holds the largest market share due to factors such as increasing count of geriatrics, along with the growing healthcare industry, which is anticipated to stimulate the demand in this region. Substantial investments by governments to strengthen public healthcare delivery is a key factor augmenting the growth of the market.

Competitive Landscape

The biosurgery market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the prominent players are vigorously making acquisitions with the other companies to consolidate their market positions across the globe.

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format
– 3 months of analyst support

レポート目次

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Geriatric Population
4.2.2 Rising Prevalence of Chronic Diseases and Related Surgeries
4.2.3 Strong Focus on R&D Leading to the Launch of New and Advanced Products
4.3 Market Restraints
4.3.1 High Price of Biosurgery Products and Rising Cost of Surgical Procedures
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Bone-Graft Substitutes
5.1.2 Soft-Tissue Attachments
5.1.3 Hemostatic Agents
5.1.4 Surgical Sealants and Adhesives
5.1.5 Adhesion Barriers
5.1.6 Staple Line Reinforcement
5.2 By Application
5.2.1 Orthopedic Surgery
5.2.2 General Surgery
5.2.3 Neurological Surgery
5.2.4 Cardiovascular Surgery
5.2.5 Gynecological Surgery
5.2.6 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Baxter International Inc.
6.1.2 B. Braun Melsungen AG
6.1.3 Becton, Dickinson and Company (C.R. Bard)
6.1.4 Johnson & Johnson
6.1.5 Medtronic PLC
6.1.6 Integra Lifesciences Holdings Corporation
6.1.7 CSL Limited
6.1.8 CryoLife Inc.
6.1.9 Hemostasis LLC
6.1.10 Betatech Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS